Esperion Therapeutics, Inc.
USD3.17
+0.02 (+0.63%)
CEO
Sheldon L. Koenig
IPO Date
2013-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.15
Prev. Close
$3.15
Day Low
$3.15
Day High
$3.17
52W Low
$0.95
52W High
$4.18
Market Cap
$0.66B
Volume
14.00M
| 53,588 |
| $3.15 |
| 18 Jun 2026 | Halladay Benjamin | Chief Financial Officer | S-Sale | Disposed | 10,773 | $3.15 |
| 1 Jun 2026 | THOMPSON JOHN CRAIG | director | A-Award | Acquired | 79,873 | $0.00 |
| 1 Jun 2026 | Shepard Jay | director | A-Award | Acquired | 79,873 | $0.00 |
| 1 Jun 2026 | Hoffman Robert E. | director | A-Award | Acquired | 79,873 | $0.00 |
| 1 Jun 2026 | Fischer Seth H. Z. | director | A-Award | Acquired | 79,873 | $0.00 |
| 1 Jun 2026 | CARROLL J MARTIN | director | A-Award | Acquired | 79,873 | $0.00 |
| 18 Mar 2026 | Looker Benjamin | Chief Legal Officer | S-Sale | Disposed | 5,708 | $2.70 |
| 18 Mar 2026 | Koenig Sheldon L. | director, officer: President and CEO | S-Sale | Disposed | 25,578 | $2.72 |